We have synthesized twelve CCK7 and CCK8 analogues with a substituted glycine at position 3 or 4. The most interesting analogues studied were N"-carboxyacylated CCK7 or CCK8 with D-tryptophan or D-alanine substitution, i. e. N"-carboxyacylated [D-TI'p3]and [D-A133]-CCK7 and N"-carboxyacylated [D-Trp4]-and [D-A134]-CCK8. These analogues stimulated pancreatic exocrine secretion in anesthetized rats to almost the same extent as CCK8, but their guinea pig gall bladder contracting activity was substantially diminished. The selective stimulation of pancreatic secretion was also confirmed in vivo in anesthetized dogs with the D-amino acid-substituted CCK7 analogues. Receivedfor publication 15 February 1985 
demonstrated that the gall bladder contracting activity of cholecystokinin (CCK) and the pancreatic enzyme secreting activity of pancreozymin (PZ) were attributed to a single molecule having a tritriacontapeptide amide structure. This component is now known as CCK33. The carboxy-terminal octapeptide (CCK8) (8), and even heptapeptide (CCK7) (l l), possess the full spectrum of the biological activities of CCK33. Proton NMR conformational analysis (4) has provided data supporting a y-turn structure for the sequence of Metz-Glyi'-Trp4 in CCK7 which is favoured by the presence of a flexible Gly as the central residue.
To explore the significance of the Gly residue for the bi logical activities of CCK, we have prepared C( §(7 and CCK8 analogues with a substituted Gly at position 3 or 4. Synthesis of CCK7 and CCK8 analogues was carried out by solution methodology using minium side-chain protection (9, 12) . Peptide chains were constructed in a stepwise manner following the peptide sequence using t-butyloxycarbonyl (Boc) protected amino acids according to the mixed anhydride or active ester method. After construction of H-Tyr-Met-X-Trp-Met-Asp-Phe-NH; or H-Asp-Tyr-Met-X-Trp-Met-Asp-Phe-NH, (X: 1)-Trp, 1)-Ala, Trp, Ala, Sar or B-Ala), the peptide was carboxyacylated with acid anhydride such as succinyl (Suc), glutaryl (Glt) and phthalyl (Pht) anhydrides, followed by sulfation of Tyr residue with pyridinesulfonic acid complex (10). [D-Try3]-CCK7 and [D-Trp4]-CCK8 were prepared by sulfating Boc-Tyr-Met-D-Trp-Trp-Met-Asp-Phe-NH; or Boc-Asp-Tyr-Met-D-Trp-Trp-Met-Asp-Phe-NH; followed by deblocking of the Boc group with trifluoroacetic acid. Each of the final products was purified extensively by DEAE-cellulose column chromatography with 0.05 M ammonium carbonate-ammonium bicarbonate buffer (pH 8.5) and reverse-phase high performance liquid chromatography (HPLC) on an ODS column with 18% acetonitrile in 0.01 M ammonium acetate buffer (pH 6.7). The CCK and PZ activities ofthe synthetic peptides were assessed by the contractile effect upon gall bladder in anesthetized guinea pigs (1) and the stimulatory effect upon pancreatic exocrine secretion in anesthetized rats (3). N'-Carboxyacylated [D-TI'p3]-CCK7 analogues were also examined simultaneously in viva by measuring gall bladder contraction and pancreatic exocrine secretion in anesthetized dogs (5). Table 1 summarizes the relative potencies of CCK and PZ activities of the synthetic CCK7 and CCK8 analogues. Substitution of the Gly residue with D-Trp in CCK7 or CCK8 resulted in drastic decreases of both activities (Table la) . This observation was in striking contrast to the effect of I)-Trp substitution of Gly" residue in luteinizing hormone-releasing hormone (LH-RH) which markedly enhanced LH-and FSHreleasing activity of LH-RH (2). a-Amino group protection of the [D-Trp]-substituted analogues with Suc group (des-amino aspartyl group) restored only PZ activity in anesthetized rats to the same magnitude as that of CCK8; while the CCK activity in anesthetized guinea pigs remained at an extremely low level (Table lb) . Suc group addition on CCK7 or CCK8 did not alter significantly their CCK and PZ activities (Table lc) , although the protection at the aminoterminal may have a prolonging effect upon the half-life of the peptides in blood as is the case with many other peptides. The Suc group on [D-Trp3]-CCK7 and [D-TI'p4]-CCK8 in combination with the D-Trp residue seems to be essential for the selectivity towards the PZ activity since pG1l1-[D-T1133]-CCK7 showed amarkedly reduced potency of both CCK and PZ activities (Table  1d ). The other two types of N"-carboxyacyl groups, Glt and Pht, both having free carboxylic group, displayed almost the same effects as that C. YANAIHARA et al. of the Suc group on CCK and PZ activities (Table 1e ). This observation suggested that the structure between the two carboxylic functions in the N"-protecting group is not a major factor responsible for the dissociation of the CCK/PZ activities.
The pancreatic exocrine secreting effects of Suc-and G111-[D-T1133]-CCK7 increased in a dosedependent manner paralleling that of CCK8 (Fig. 1) . Removal of the indole function from D-Trp in position 3 did not cause a marked change in the characteristic selectivity for PZ activity. SLIC-[D-A133]-CCK7 possessed an effect on pancreatic secretion much stronger than that on gall bladder contraction (Table lf) . This characteristic dissociation of CCK/PZ activities was specific for the D-configuration of the hydrophobic amino acids in position 3. In fact, the CCK activities of Suc-[Trp3]-CCK7 and Suc-[Ala3]-CCK7 were extremely low as was the case of the 1)amino acid substitution, but their PZ activities were also one order of magnitude less potent than that of CCK8 (Table lg) . Suc-[Sar3]-CCK7 showed the same tendency of dissociation of CCK/PZ activities, while the [B-Alai] analogue was much less potent (Table lh) .
The selective stimulation of pancreatic secretion by the D-Trp-substituted analogues was also confirmed in viva in anesthetized dogs. sion curve of CCK and PZ activities was 1.15 for CCK8 and 0.34 for SLlC-[D-T1133]-CCK7 (Fig. 2) , indicating an apparent dissociation of the two activities in SLIC-[D-T1133]-CCK7 in this assay ststem. had more PZ than CCK activity (7) . In this study, we found that new carboxyacylated CCK7 and CCK8 analogues with a substituted Gly residuehave PZ activity as potent as CCK8 but are almost devoid ofCCK activity. The flexibility ofthe Gly residue may play a crucial role for CCK7 or CCK8 molecules to exert these selective activities. The selective stimulation of pancreatic secretion by these new CCK analogues may result from increased rigidity in structural conformation so as to fit preferentially the receptor for PZ activity.
These newly synthesized CCK7 and CCK8 analogues will be powerful tools for distinguishing between CCK and PZ receptors for the CCK molecule. 
